Cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory drugs in the management of arthritis.

Published

Journal Article (Review)

The management of arthritis pain should be individualized to the needs and characteristics of the patient. The decision to use nonsteroidal anti-inflammatory drugs (NSAIDs), and in particular the cyclooxygenase-2 (COX-2) inhibitors, is multidimensional. The challenge is to achieve optimal pain relief at the minimum dose to minimize adverse effects. Whenever possible, NSAIDs should be given as monotherapies or in combinations at the lowest effective doses. The COX-2 inhibitors are a safe choice for most patients who are at low risk for a cardiovascular event. Individuals who are at risk for thromboses should not receive unopposed COX-2 inhibitors; COX-2 should be given in combination with low-dose aspirin which is expected to be cardioprotective in high-risk patients.

Full Text

Duke Authors

Cited Authors

  • Kraus, VB

Published Date

  • June 2003

Published In

Volume / Issue

  • 8 / 2

Start / End Page

  • 187 - vii

PubMed ID

  • 12911235

Pubmed Central ID

  • 12911235

International Standard Serial Number (ISSN)

  • 1083-7515

Digital Object Identifier (DOI)

  • 10.1016/s1083-7515(03)00035-4

Language

  • eng

Conference Location

  • United States